Medical Device News Magazine

Clinical Study Shows Vista.ai Significantly Reduces Cardiac MRI Scan Time

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Vista.ai, a pioneer and leader in automated MRI solutions, today announced results from a clinical adaptation study on the company’s One Click MRI™ software, led by Dr. Raymond KwongDirector, Cardiac Magnetic Resonance Imaging for Harvard-affiliated Brigham and Women’s Hospital.

The findings show that Vista.ai’s AI-guided image acquisition software improves cardiac MRI (CMR) scan times and achieves high adoption rates by hospital imaging staff. Dr. Kwong will discuss the learnings and implications of the study at an interactive breakfast symposium at 7:20 a.m. PST on Jan. 27, 2023, at the SCMR Scientific Sessions in San Diego.

Dr. Kwong evaluated the use of One Click MRI across approximately 1,100 consecutive studies for cardiomyopathy and structural heart disease, comparing traditional CMR exams against both partial and full AI-assisted scans from April to September 2022.

With respect to CMR exam time, Dr. Kwong’s study found that:

  • Full AI-assisted scans – where a technologist uses One Click MRI to oversee the exam with no manual operation – were 31% shorter than non-AI scans. 

  • 90% of full AI-assisted scans were completed within 45 minutes, while only 25% of unassisted scans were completed within that timeframe.

  • Full AI-assisted scan times were threefold more consistent than unassisted scan times. Both had minimum times of 26 to 27 minutes; however, maximum times were 64 minutes versus 161 minutes, respectively.

Failed adoption of other promising technologies in the medical field has spotlighted the critical importance of gaining support of frontline workers. Notably, Dr. Kwong’s study found that voluntary use of One Click MRI steadily grew as technologists witnessed the software’s ease of use and benefits firsthand. Technologist adoption increased from 13% during the first full month One Click MRI was available (May) to 55% at the end of the study (September).

“An influx of patients with COVID-19-induced cardiac issues further strained the operation of our CMR program at Brigham. Before initiating the One Click MRI study, some outpatients were waiting up to three to four weeks for a CMR scan. Even our sickest inpatients would often have to wait two to five days for a scan,” Dr. Kwong said. “We believe that with continued use of One Click MRI, we will further reduce scan times to an average of 30 minutes, shrink the backlog to improve upon pre-pandemic levels, and sustain a CMR growth rate of about 15% a year.”

A case study summarizing Dr. Kwong’s full clinical findings is available at vista.ai/evidence/studies. In addition to demonstrations of One Click MRI, the case study will also be on display at the Vista.ai’s SCMR booth (#503). 

“A standard CMR is complex and unpredictably long, causing unnecessary stress and burnout for clinicians and discomfort for patients,” said Itamar Kandel, Vista.ai’s CEO. “We applaud Dr. Kwong’s rigorous clinical evaluation of One Click MRI across more than 1,000 patients over a six-month timeframe, and we are thrilled with his conclusions that the software yields positive impacts on clinician workflow, MRI scanner throughput, patient convenience and time to diagnosis. These findings serve as a foundation of evidence to fuel our efforts to make CMR available to all patients who can benefit.”

One Click MRI is initially focused on automating and simplifying a CMR exam, which is increasingly considered the gold-standard cardiac diagnostic, yet is notoriously difficult and time-consuming to complete. Today, specially-trained CMR technologists need to perform the exam, and in the U.S., there is only one such technologist for every 20 MRI machines. Vista.ai recently announced planned expansion beyond the heart to other anatomies and clinical areas.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”